Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Common Stock | Options Exercise | +639 | +3.14% | 21K | Sep 10, 2024 | Direct | F1 | ||
transaction | GILD | Common Stock | Tax liability | -$25K | -307 | -1.46% | $81.44 | 20.7K | Sep 10, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Restricted Stock Unit | Options Exercise | -639 | -2.12% | 29.5K | Sep 10, 2024 | Common Stock | 639 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
F2 | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |